Novo Nordisk will report the topline results from the REDEFINE-1 trial of CagriSema in obese patients before the end of the year. See why NVO stock is a Buy.

Pharmaceutical company Novo Nordisk has launched its mega-popular weight-loss drug Wegovy in China — but for a tiny fraction ...

Figures from the Irish League of Credit Unions, which represents 90 per cent of the credit unions in the State, show that ...

Ozempic and Mounjaro were among the medicines The i Paper found promoted for sale in weight loss groups on the social media ...

A man walks past a corporate office of Adani Group in Gurugram, India, November 22, 2024. REUTERS/Priyanshu Singh/File Photo Adani dollar bond prices fell to almost one-year lows on Monday as ...

It looks like you're using an old browser. To access all of the content on Yr, we recommend that you update your browser. It looks like JavaScript is disabled in your browser. To access all the ...